ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1600200
This article is part of the Research TopicPhysiology and Pathophysiology of PlacentaView all 9 articles
Intraplacental choriocarcinoma and Spontaneous fetomaternal hemorrhage: cross clues and bring a case to book
Provisionally accepted
- 1Department of Gynecology & Obstetrics, Liaocheng People’s Hospital, School of Medicine, Liaocheng University, Liaocheng, China, Liaocheng, China
- 2Department of Gynecology Oncology, Shandong Provincial Key Medical and Health Laboratoy of Liaocheng Infectious Disease Hospital, Liaocheng, China
- 3Department of Gynecology & Obstetrics Qingdao Hospital of Traditional Chinese Medicine, Qingdao, China
- 4School of Medicine, Liaocheng University, Liaocheng, Shandong Province, China
- 5Department of Pathology, Liaocheng People's Hospital, Liaocheng, Shandong Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Intraplacental choriocarcinoma (IC) is an extremely rare malignancy of the placenta, often associated with fetomaternal hemorrhage (FMH). This combination is challenging to diagnose antepartum and is associated with high perinatal mortality, predominantly due to severe fetal anemia.Methods: We report a case of IC associated with FMH and conducted a systematic review of cases published in the English and Chinese literature. Data from these cases were combined to evaluate clinical characteristics, diagnostic approaches, treatment options and outcomes.Results: A 31-year-old woman presented with decreased fetal movements at 34+2 weeks of gestation. Following an emergent cesarean section, the infant was found to be severely anemic and passed away shortly after delivery. Placental histopathology revealed IC. The patient received chemotherapy with EMA/CO and showed no evidence of metastasis or recurrence over 12 months of follow-up. The systematic review identified 35 cases of IC associated with FMH. Common diagnostic clues included decreased fetal movements, abnormal middle cerebral artery Doppler studies, and FMH. Despite the severe perinatal outcomes, maternal prognosis was generally favorable with chemotherapy in cases of metastasis. Conclusion: IC with FMH is a rare but life-threatening condition requiring high clinical suspicion and prompt placental histopathology for diagnosis. Early recognition of fetal anemia and FMH is essential for timely intervention.
Keywords: Intraplacental choriocarcinoma, Fetomaternal hemorrhage, Pathology, Clinical Characteristics, outcomes
Received: 26 Mar 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 Wang, Li, Bai, Du, Lu, Li and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiuyu Wang, Department of Pathology, Liaocheng People's Hospital, Liaocheng, 252000, Shandong Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.